CD36 and diabetic kidney disease: The external validity of the findings requires cautious interpretation, particularly when applied to populations with diverse demographic and clinical characteristics.3, Limited Mechanistic Investigation: Although the study identified associations between sCD36 levels and DKD progression, the underlying molecular mechanisms—especially the regulatory effects of GLP-1RAs on CD36 expression and their renoprotective actions—remain insufficiently explored.